Merck (MRK) Cash & Equivalents (2009 - 2026)
Merck (MRK) posted Cash & Equivalents of $6.85 billion for Q2 2026, down 14.5% from $8.01 billion a year earlier but up 28.6% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Merck's Cash & Equivalents came in at $14.57 billion, up 10.0% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 12.6% (FY2020 to FY2025).
- In prior years, Merck's Cash & Equivalents was $13.24 billion in FY2024 (+93.6%), $6.84 billion in FY2023 (-46.1%), $12.69 billion in FY2022 (+56.8%) and $8.1 billion in FY2021 (+0.6%).
- Quarterly Cash & Equivalents has run from a low of $5.33 billion in Q1 2026 to a high of $18.17 billion in Q3 2025 over five years.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 21.3%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2024, with growth of 99.7%; the weakest was Q4 2023, with a decline of 46.1%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $5.33 billion (Q1 2026), $14.57 billion (Q4 2025) and $18.17 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 6.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.85 Bn |
| Mar 31, 2026 | 5.33 Bn |
| Dec 31, 2025 | 14.57 Bn |
| Sep 30, 2025 | 18.17 Bn |
| Jun 30, 2025 | 8.01 Bn |
| Mar 31, 2025 | 8.63 Bn |
| Dec 31, 2024 | 13.24 Bn |
| Sep 30, 2024 | 14.59 Bn |
| Jun 30, 2024 | 11.30 Bn |
| Mar 31, 2024 | 5.58 Bn |
| Dec 31, 2023 | 6.84 Bn |
| Sep 30, 2023 | 8.61 Bn |
| Jun 30, 2023 | 5.66 Bn |
| Mar 31, 2023 | 9.71 Bn |
| Dec 31, 2022 | 12.69 Bn |
| Sep 30, 2022 | 11.15 Bn |
| Jun 30, 2022 | 9.68 Bn |
| Mar 31, 2022 | 8.56 Bn |
| Dec 31, 2021 | 8.10 Bn |
| Sep 30, 2021 | 10.02 Bn |
API Access
Merck Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();